Ocugen tumbles after FDA asks for more data on its COVID-19 vaccine candidate Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Asana (ASAN) up 6% after Baird analyst Rob Oliver raised the firm's price target on the stock to $50 from $40 following the company's unveiling of a suite of personal-productivity features that aim to bridge the gap between team-agility and individualization
- Barkbox (BARK) up 3% after Jefferies analyst Stephanie Wissink initiated coverage of shares with a Buy rating and $14 price target citing the company's underlying subscriber growth
UP AFTER EARNINGS -
- Signet Jewelers (SIG) up 7%
- Pentair (PNR) up 1%
- RH (RH) up 9%
DOWN AFTER EARNINGS -
- FuelCell (FCEL) down 11%
- GameStop (GME) down 8%
- KLX Energy (KLXE) down 13%
LOWER -
- Ocugen (OCGN) down 28% after announcing that upon recommendation from the FDA, it will no longer pursue an Emergency Use Authorization for its Covid-19 vaccine candidate and instead will pursue submission of a biologics license application for Covaxin
- Clarivate (CLVT) down 2% after its 38.462M share secondary priced at $26
Symbols:
ASAN BARK SIG PNR RH - $612.52 /
-16.48 (-2.62%)
FCEL GME KLXE OCGN CLVT - $26.36 /
-6.455 (-19.67%)
Keywords: Fly Intel, Wall Street, Top Stories, Stocks